E&L Testing Market Growth To Be Driven By Single-Use Systems
The worldwide extractable and leachable- E&L testing services market is all set to value $2.57 million by 2030, as per the latest report by...
CAR-NK Cell Therapy Trial Long-Term Findings Get Revealed
In a recent development, researchers from the US have gone on to report some promising outcomes out of a Phase I/II trial when it...
Cancer Care Whole Genome Sequencing: Compelling Proof Found
Blending the routine clinical data along with the whole genome sequence- WSG data at scale goes on to support clinicians when it comes to...
2024 Has A Lot Many Questions In Store For Pharma Companies
The advent of powerful new drugs in the case of obesity has gone on to reshape the pharma sector, thereby transforming Eli Lilly as...
UK Study Supports Whole Genome Sequencing In Cancer Care
A novel benchmark study in the UK has gone on to show that blending whole-genome sequencing- WGS and real-world clinical data at a national...
Generic Drugs Safety Test Requests Pushed Back By The FDA
Apparently, when a grocery store goes on to steeply discount rotting cuts of meat or produce, would one buy them? May be not. If...
The Biopharma Spectrum May See Regulation Shifts In 2024
The scenario is that the regulators are all ramping up pressure when it comes to the biopharma industry in 2024. Pharma companies not only...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

























